35153755|t|Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Protects Striatal Cells and Improves Motor Function in Huntington's Disease Models: Role of PAC1 Receptor.
35153755|a|Huntington's disease (HD) is a hereditary neurodegenerative disorder caused by the expression of mutant huntingtin (mHtt). One of the main features of HD is the degeneration of the striatum that leads to motor discoordination. Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide that acts through three receptors named PAC1R, VPAC1R, and VPAC2R. In the present study, we first investigated the effect of PACAP on STHdhQ7/Q7 and STHdhQ111/Q111 cells that express wild-type Htt with 7 and mHtt with 111 glutamines, respectively. Then we explored the capacity of PACAP to rescue motor symptoms in the R6/1, a murine model of HD. We found that PACAP treatment (10-7 M) for 24 h protects STHdhQ111/Q111 cells from mHtt-induced apoptosis. This effect is associated with an increase in PAC1R transcription, phosphorylation of ERK and Akt, and an increase of intracellular c-fos, egr1, CBP, and BDNF protein content. Moreover, the use of pharmacological inhibitors revealed that activation of ERK and Akt mediates these antiapoptotic and neurotrophic effects of PACAP. To find out PAC1R implication, we treated STHdh cells with vasoactive intestinal peptide (VIP), which exhibits equal affinity for VPAC1R and VPAC2R, but lower affinity for PAC1R, in contrast to PACAP which has same affinity for the three receptors. VIP reduced cleaved caspase-3 protein level, without promoting the expression of c-fos, egr1, CBP, and the neurotrophin BDNF. We next measured the protein level of PACAP receptors in the striatum and cortex of R6/1 mice. We observed a specific reduction of PAC1R at the onset of motor symptoms. Importantly, the intranasal administration of PACAP to R6/1 animals restored the motor function and increased the striatal levels of PAC1R, CBP, and BDNF. In conclusion, PACAP exerts antiapoptotic and neurotrophic effects in striatal neurons mainly through PAC1R. This effect in HD striatum allows the recovery of motor function and point out PAC1R as a therapeutic target for treatment of HD.
35153755	0	50	Pituitary Adenylate Cyclase-Activating Polypeptide	Gene	11516
35153755	52	57	PACAP	Gene	11516
35153755	114	134	Huntington's Disease	Disease	MESH:D006816
35153755	166	186	Huntington's disease	Disease	MESH:D006816
35153755	188	190	HD	Disease	MESH:D006816
35153755	197	234	hereditary neurodegenerative disorder	Disease	MESH:D020271
35153755	270	280	huntingtin	Gene	15194
35153755	317	319	HD	Disease	MESH:D006816
35153755	327	355	degeneration of the striatum	Disease	MESH:D020267
35153755	370	391	motor discoordination	Disease	MESH:C562757
35153755	393	443	Pituitary adenylate cyclase-activating polypeptide	Gene	11516
35153755	445	450	PACAP	Gene	11516
35153755	510	515	PAC1R	Gene	11517
35153755	529	536	VPAC2R.	Gene	22355
35153755	595	600	PACAP	Gene	11516
35153755	604	612	STHdhQ7/	CellLine	CVCL:M590
35153755	619	633	STHdhQ111/Q111	CellLine	CVCL:M591
35153755	663	666	Htt	Gene	15194
35153755	751	756	PACAP	Gene	11516
35153755	789	793	R6/1	CellLine	CVCL:D507
35153755	797	803	murine	Species	10090
35153755	813	815	HD	Disease	MESH:D006816
35153755	831	836	PACAP	Gene	11516
35153755	874	888	STHdhQ111/Q111	CellLine	CVCL:M591
35153755	970	975	PAC1R	Gene	11517
35153755	1010	1013	ERK	Gene	26413
35153755	1018	1021	Akt	Gene	11651
35153755	1056	1061	c-fos	Gene	14281
35153755	1063	1067	egr1	Gene	13653
35153755	1069	1072	CBP	Gene	12914
35153755	1078	1082	BDNF	Gene	12064
35153755	1176	1179	ERK	Gene	26413
35153755	1184	1187	Akt	Gene	11651
35153755	1245	1250	PACAP	Gene	11516
35153755	1264	1269	PAC1R	Gene	11517
35153755	1294	1299	STHdh	CellLine	CVCL:M591
35153755	1311	1340	vasoactive intestinal peptide	Gene	22353
35153755	1342	1345	VIP	Gene	22353
35153755	1393	1399	VPAC2R	Gene	22355
35153755	1424	1429	PAC1R	Gene	11517
35153755	1446	1451	PACAP	Gene	11516
35153755	1501	1504	VIP	Gene	22353
35153755	1521	1530	caspase-3	Gene	12367
35153755	1582	1587	c-fos	Gene	14281
35153755	1589	1593	egr1	Gene	13653
35153755	1595	1598	CBP	Gene	12914
35153755	1621	1625	BDNF	Gene	12064
35153755	1711	1715	R6/1	CellLine	CVCL:D507
35153755	1716	1720	mice	Species	10090
35153755	1758	1763	PAC1R	Gene	11517
35153755	1842	1847	PACAP	Gene	11516
35153755	1851	1855	R6/1	CellLine	CVCL:D507
35153755	1929	1934	PAC1R	Gene	11517
35153755	1936	1939	CBP	Gene	12914
35153755	1945	1949	BDNF	Gene	12064
35153755	1966	1971	PACAP	Gene	11516
35153755	2053	2059	PAC1R.	Gene	11517
35153755	2075	2077	HD	Disease	MESH:D006816
35153755	2139	2144	PAC1R	Gene	11517
35153755	2186	2188	HD	Disease	MESH:D006816
35153755	Positive_Correlation	11516	11651
35153755	Bind	11517	22353
35153755	Positive_Correlation	11516	12914
35153755	Negative_Correlation	12367	22353
35153755	Association	MESH:D006816	11516
35153755	Positive_Correlation	11516	26413
35153755	Positive_Correlation	11516	12064
35153755	Positive_Correlation	11516	14281
35153755	Bind	11516	22355
35153755	Positive_Correlation	11516	13653
35153755	Bind	22353	22355
35153755	Positive_Correlation	11516	11517

